BioMérieux, a medtech firm based in France, is to acquire US rival BioFire, a spin-out of the University of Utah, for $450m.

Launched 20 years ago, the Salt Lake City-based BioFire specialises in producing FilmArray, a medical diagnostics kit which can identify 20 bacterial and viral infections in one hour. As part of the deal, which will see BioMérieux acquire 100% ownership of BioFire, the French medtech will not only be able to add FilmArray to its own product line-up,…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?